Described herein is the synthesis of adhesive from simple adhesive coacervates and their uses thereof. The adhesives are composed of (a) a polyanion in the absence of a polycation, wherein the polyanion comprises at least one crosslinking group capable of covalently crosslinking with itself, and (b) a sufficient amount of a complimentary multivalent cation or multivalent anion to produce the simple coacervate. The adhesives have numerous medical and non-medical applications.

Described herein is the synthesis of adhesive from simple adhesive coacervates and their uses thereof. The adhesives are composed of (a) a polyanion in the absence of a polycation, wherein the polyanion comprises at least one crosslinking group capable of covalently crosslinking with itself, and (b) a sufficient amount of a complimentary multivalent cation or multivalent anion to produce the simple coacervate. The adhesives have numerous medical and non-medical applications.

Described herein is the synthesis of adhesive from simple adhesive coacervates and their uses thereof. The adhesives are composed of (a) a polyanion in the absence of a polycation, wherein the polyanion comprises at least one crosslinking group capable of covalently crosslinking with itself, and (b) a sufficient amount of a complimentary multivalent cation or multivalent anion to produce the simple coacervate. The adhesives have numerous medical and non-medical applications.

An acrylic adhesive composition is provided comprising a free-radical polymerizable monomer, an initiation system and a co-accelerator that enhances the reactivity of the initiation system by increasing the reaction rate between the oxidizing agent and the reducing agent. The free radical-polymerizable monomer preferably comprises methyl methacrylate (MMA), the initiator system preferably comprises N,N-diisopropanol-p-toluidine (DIIPT) and benzoyl peroxide (BPO), and the co-accelerator preferably comprises 1,4-diazabicyclo[2.2.2]octane (or triethylene diamine (TDA)).

An acrylic adhesive composition is provided comprising a free-radical polymerizable monomer, an initiation system and a co-accelerator that enhances the reactivity of the initiation system by increasing the reaction rate between the oxidizing agent and the reducing agent. The free radical-polymerizable monomer preferably comprises methyl methacrylate (MMA), the initiator system preferably comprises N,N-diisopropanol-p-toluidine (DIIPT) and benzoyl peroxide (BPO), and the co-accelerator preferably comprises 1,4-diazabicyclo[2.2.2]octane (or triethylene diamine (TDA)).

A halogen-free flame retardant adhesive comprises an acrylic copolymer preparable by polymerization of monomers comprising a first monomer which comprises a low glass transition temperature (Tg) monomer, a second monomer which comprises a high Tg monomer, wherein at least one of the first and second monomers comprises a (meth)acrylate, and a phosphinate containing monomer.

A halogen-free flame retardant adhesive comprises an acrylic copolymer preparable by polymerization of monomers comprising a first monomer which comprises a low glass transition temperature (Tg) monomer, a second monomer which comprises a high Tg monomer, wherein at least one of the first and second monomers comprises a (meth)acrylate, and a phosphinate containing monomer.

A resin composition may include at least one urethane (meth)acrylate oligomer, at least one (meth)acrylate monomer, and at least one photoinitiator. The urethane (meth)acrylate oligomer may include a first urethane (meth)acrylate oligomer derived from a phosphate ester-containing polyol represented by Formula 1, and the first urethane (meth)acrylate oligomer may have a number-average molecular weight of about 805 to about 955. Accordingly, the resin composition may exhibit the characteristics of a low viscosity before being cured, and excellent or suitable shear modulus and peel strength after being cured. ##STR00001##

A resin composition may include at least one urethane (meth)acrylate oligomer, at least one (meth)acrylate monomer, and at least one photoinitiator. The urethane (meth)acrylate oligomer may include a first urethane (meth)acrylate oligomer derived from a phosphate ester-containing polyol represented by Formula 1, and the first urethane (meth)acrylate oligomer may have a number-average molecular weight of about 805 to about 955. Accordingly, the resin composition may exhibit the characteristics of a low viscosity before being cured, and excellent or suitable shear modulus and peel strength after being cured. ##STR00001##

To provide an inhibitor for inhibiting protein adhesion capable of easily forming a coating layer which is excellent in water resistance, from which coating components are less likely to be eluted, on which protein is less likely to be adsorbed and which is excellent in biocompatibility; a coating solution; a medical device having a coating layer employing this inhibitor for inhibiting protein adhesion; a method for producing the same; and a fluoropolymer to be used in this inhibitor for inhibiting protein adhesion. A compound for inhibiting protein adhesion comprising a fluoropolymer that has units having a biocompatible group, a fluorine atom content of from 5 to 60 mass % and a proportion P represented by the following formula of from 0.1 to 4.5%. (Proportion P)=((proportion (mass %) of units having a biocompatible group to all units of the fluoropolymer))/(fluorine atom content (mass %) of the fluoropolymer))100.